Xiamen Origin Biotech Co., Ltd. is a ‘State Hi-tech Enterprise’ integrating R&D, manufacture, and sales of veterinary and human API and intermediates.
Origin’s products are Hormones, including Proteins & Peptides, Prostaglandins, and other small molecule API products. Among them, Chorionic Gonadotrophin (HCG), Serum Gonadotrophin (PMSG/ECG), Cloprostenol, Cloprostenol Sodium, D-Cloprostenol Sodium, Altrenogest, Dinoprost Tromethamine, Gonadorelin Acetate, Luteinizing Hormone Releasing Hormone A2 (Alarelin Acetate), Luteinizing Hormone Releasing Hormone A3 (Triptorelin Acetate), Buserelin Acetate, Pimobendan, Oxytocin, Denaverine Hydrochloride and Neostigmine Methyl Sulfate have all been granted GMP certificates. Moreover, its Trilostane, Carbetocin, Deslorelin Acetate, Fertirelin Acetate and many other product are also very competitive in terms of both quality and price, gaining customers' unanimous appreciation both domestic and overseas.
Origin has established a subsidiary company, Henan Medscience Pharmaceuticals Co., Ltd, which is dedicated in the production of human-use API and Intermediates. At present, Medscience features Chorionic Gonadotrophin (HCG), Menotrophins (HMG), Urofollitrophin (FSH), Urokinase (UK), and Ulinastatin (UTI) as its main products. Meanwhile, Medscience is making preparations for FDA and EU GMP certification, making its continuous effort to provide products and services of the best quality to domestic and foreign customers.
more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights: